학술논문
A privileged dual action Alzheimer’s disease therapeutic platform targeting immunopathic and proteopathic mechanisms: (E)-3-styrylindoles as inhibitors of indoleamine 2,3-dioxygenase-mediated tryptophan metabolism and β-amyloid aggregation
Document Type
Article
Author
Source
In: Canadian Journal of Chemistry . (Canadian Journal of Chemistry, September 2022, 100(9):660-675)
Subject
Language
English
ISSN
00084042